Clinical trials
Phase 1 Neurodegenerative Diseases trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| MODAG GmbH | 3 |
| Alnylam Pharmaceuticals | 1 |
| Eli Lilly and Company | 1 |
| Ono Pharmaceutical Co., Ltd. | 1 |
| PepGen Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurodegenerative Diseases | 7 |
| Alzheimer Disease | 4 |
| Tauopathies | 4 |
| Multiple System Atrophy | 3 |
| Parkinson Disease | 3 |
| Nervous System Diseases | 2 |
| Brain Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Cognitive Dysfunction | 1 |
| Dementia | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.